Skip to main navigation
Skip to search
Skip to main content
Illinois Experts Home
LOGIN & Help
Home
Profiles
Research units
Research & Scholarship
Datasets
Honors
Press/Media
Activities
Search by expertise, name or affiliation
The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies
Roy Lirov
, Francis P. Worden
,
Mark S. Cohen
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The Treatment of Advanced Thyroid Cancer in the Age of Novel Targeted Therapies'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Tyrosine Kinase Inhibitor
100%
Advanced Thyroid Cancer
100%
Novel Targeted Therapy
100%
Patient Needs
50%
Thyroid Cancer
50%
Metastatic Disease
50%
Quality of Life
50%
Targeted Therapy
50%
Targeted Drugs
50%
Systemic Treatment
50%
Living with
50%
Overall Survival
50%
New Agents
50%
Advanced Disease
50%
Thyroid Patients
50%
Medicine and Dentistry
Thyroid Cancer
100%
Targeted Therapy
100%
Tyrosine-Kinase Inhibitor
50%
Quality of Life
25%
Metastatic Carcinoma
25%
Systemic Therapy
25%
Overall Survival
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Thyroid Cancer
100%
Protein Tyrosine Kinase Inhibitor
50%
Systemic Treatment
25%
Overall Survival
25%
Diseases
25%